| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 321,60 | 322,10 | 18:12 | |
| 321,35 | 322,45 | 18:12 |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 349,00 | 10 | |||
| 338,10 | 1 | |||
| 323,35 | 25 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/amg.htm [/URL] | ||||
| 25 | 322,35 | |||
| 1.053 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 1.078 | 0,033 | 36 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 16:59:43 | 321,85 | 1 |
| 16:57:28 | 321,90 | 5 |
| 16:49:09 | 321,95 | 1 |
| 16:28:21 | 321,85 | 200 |
| 15:20:39 | 318,55 | 1 |
| 15:02:38 | 318,90 | 96 |
| 15:02:38 | 318,90 | 9 |
| 14:25:00 | 316,70 | 5 |
| 14:17:59 | 318,95 | 19 |
| 13:53:57 | 318,90 | 1 |
| 13:41:34 | 319,20 | 16 |
| 13:27:43 | 319,05 | 70 |
| 11:43:19 | 319,05 | 6 |
| 11:34:41 | 319,00 | 1 |
| 11:31:08 | 318,80 | 20 |
| 11:13:20 | 316,35 | 12 |
| 11:03:42 | 319,05 | 10 |
| 10:59:29 | 318,95 | 46 |
| 10:54:11 | 318,65 | 4 |
| 10:34:57 | 318,50 | 1 |
| Tagesumsatz Xetra | +5,15 +1,63 % | 597 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AMGEN Aktie jetzt für 0€ handeln | |||||
| 16:10 | 'SNL' pokes fun at mysteries of Amgen's Otezla for plaque psoriasis | 7 | FiercePharma | ||
| Do | Leerink Partners senkt Amgen-Prognose für Q1 wegen Lagerbestandsabbau | 31 | Investing.com Deutsch | ||
| Do | Leerink Partners cuts Amgen Q1 estimates on inventory drawdown | 21 | Investing.com | ||
| Di | Amgen EVP Sold $20.77M In Company Stock | 27 | Benzinga.com | ||
| 02.03. | AAPL, AA, BKR, and AMGN are among the top stocks for momentum, says Oppenheimer | 11 | Seeking Alpha |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 16:09 | Cathie Wood schlägt wieder zu: Star-Investorin kauft jetzt diese Aktien (BioNTech dabei) | BÖRSE ONLINE | Die Star-Investorin Cathie Wood hat die Schwächephase an den Märkten für weitere Käufe genutzt und eine Reihe spannender Aktien gekauft. Mit dabei ist unter anderem der deutsche Wert BioNTech. Fondsmanagerin... ► Artikel lesen | |
| 13:12 | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease | GlobeNewswire (Europe) | Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally... ► Artikel lesen | |
| 13:14 | Coeptis Therapeutics: Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build | ACCESS Newswire | BRISTOL, TN / ACCESS Newswire / March 9, 2026 / When Coeptis Therapeutics Holdings, Inc. (Nasdaq:COEP) and Z Squared Inc. announced their transformational merger in April 2025, the process ahead was... ► Artikel lesen | |
| 13:25 | Gubra A/S: AbbVie reports Positive Phase 1 Multiple Ascending Dose Results for ABBV-295, a Long-Acting Amylin Analog | GlobeNewswire (Europe) | Gubra's partner AbbVie today announced positive topline results from the 12 and 13-weeks Phase 1 Multiple Ascending Dose (MAD) trial showing that ABBV-295 was well tolerated with a dose-dependent significant... ► Artikel lesen | |
| 13:00 | NewcelX Ltd.: NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes | PR Newswire | Collaboration Integrates Stem-Cell-Derived Islets with Targeted Immune Modulation
ZURICH, Switzerland, March 9, 2026 /PRNewswire/ -- NewcelX Ltd. ("NewcelX") (Nasdaq:... ► Artikel lesen |